+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Nuclear Medicine Therapeutics Market Analysis & Forecast 2024-2034: Market By Type; By Application; By End-user; and By Region

  • PDF Icon

    Report

  • 145 Pages
  • October 2023
  • Region: Global
  • Erevna Healthcare
  • ID: 5890314
The global nuclear medicine therapeutics market size was estimated to be USD 9.05 billion in 2023 and is expected to reach at USD 68.22 billion by 2034 with a CAGR of 20.16% during the forecast period 2024-2034. Surge in prevalence of cases of cancers, bone deformities, & neurological malignancies, growing awareness regarding nuclear medicine, increasing demand for early detection & treatment of such diseases, rising awareness & utility of radioisotopes in nuclear medicine therapeutics, surge in research & development activities for the formulation innovative nuclear medicine therapeutics, growing demand for radioisotopes, increasing advancements in technology, and rising approval of advanced nuclear medicine by regulatory bodies are some of the key factors boosting the market growth.

Rising approval of advanced nuclear medicine by regulatory bodies is predicted to boost the market growth during the forecast period. Nuclear medicines consist of specialized pharmaceutical compounds containing radioactive isotopes. These unique medication formulations, containing radioisotopes, play a significant role in diagnoses and treatments across several critical medical fields, including neurology, cardiology, oncology, and more, and have gained increased recognition for their efficiency in recent years. For instance, in March 2022, The US Food and Drug Administration (FDA) has granted approval for the usage of Pluvicto (177Lu-PSMA-617) in the treatment of metastatic prostate cancer among adult patients.

By type, diagnostic nuclear medicine was the highest revenue-grossing segment in the global nuclear medicine therapeutics market in 2023 owing to effective imaging of patients with diverse cancer types, procedure volume expansion, rising launch of advanced products for the diagnosis of several disorders, and growing number of clinical trial procedures. For instance, in August 2022, At the 35th Annual Congress of the European Association of Nuclear Medicine (EANM), Plus Therapeutics, Inc., shared promising findings from two ongoing clinical studies assessing the potential of the investigational targeted radiotherapeutic known as Rhenium-186 NanoLiposome (186RNL) in treating leptomeningeal metastases (LM) and recurrent glioblastoma (GBM). Additionally, therapeutic nuclear medicine is predicted to grow at fastest CAGR during the forecast period owing to the therapy's relative efficacy, the benefits of various treatment alternatives, growing interest in therapeutic items by market players, and increasing launch of advanced products.

By application, oncology was the highest revenue-grossing segment in the global nuclear medicine therapeutics market in 2023 owing to surge in incidences of cancer, rising focus on development of innovative nuclear medicine therapeutics for cancer treatment, increasing launch of new products, and growing approvals by regulatory bodies. For instance, in March 2022, The US FDA granted approval to Novartis for Locametz, a diagnostic imaging agent that utilizes gallium-68 radiolabeling to detect lesions that are positive for Prostate-specific membrane antigen (PSMA). Additionally, cardiology is predicted to grow at fastest CAGR during the forecast period owing to the rising usage of nuclear medicines for the diagnosis & treatment of cardiovascular diseases, growing prevalence of cardiovascular diseases, and increasing introduction of innovative products.

By end-user, hospitals was the highest revenue-grossing segment in the global nuclear medicine therapeutics market in 2023 owing to surge in number of diagnostic imaging procedures performed within hospitals, growing demand for early diagnosis of the disease, and increasing research & development activities. For instance, in February 2023, Telix Pharmaceuticals Limited has declared the effective conclusion of a collaborative research endeavor alongside Heidelberg University Hospital (UKHD) according to the terms of their Research Cooperation Agreement. The central aim of this initiative was to create and verify a theranostic compound through a generator-based approach. This compound is intended for addressing urologic oncology, focusing on PSMA targeting and employing the beta-emitting rhenium-188 (188Re) isotope. Additionally, diagnostic centres is predicted to grow at fastest CAGR during the forecast period owing to the enormous procedure volumes and an increase in the number of diagnostic institutes.

North America region is anticipated for the highest revenue share during the forecast period owing to the growing prevalence of cancer & cardiovascular disorders, rising healthcare infrastructure, increasing awareness regarding nuclear medicine therapeutics among population, surge in use of radiopharmaceuticals in diagnosis and therapeutics, growing research studies on the nuclear medicine therapeutics, and rising focus on development of advanced nuclear radioisotopes. For instance, in January 2023, NorthStar Medical Radioisotopes, located in the United States, has reached a significant achievement in the progression of its novel technology aimed at producing the crucial medical radioisotope molybdenum-99 (Mo-99) without relying on uranium. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the rising awareness regarding imaging diagnostics, surge in number of nuclear imaging procedures, growing prevalence of cardiovascular disorders, and increasing initiatives by market players. For instance, in March 2022, Penang Adventist Hospital (PAH) has revealed the opening of a private nuclear medicine center in the northern region of Thailand.

Segmentation: Nuclear Medicine Therapeutics Market Report 2022 - 2033

Nuclear Medicine Therapeutics Market Analysis & Forecast by Type 2023 - 2034 (Revenue USD Bn)

Diagnostic Nuclear Medicine

  • SPECT Radiopharmaceuticals
  • PET Radiopharmaceuticals

Therapeutic Nuclear Medicine

  • Alpha Emitters
  • Beta Emitters
  • Brachytherapy Isotopes

Nuclear Medicine Therapeutics Market Analysis & Forecast by Application 2023 - 2034 (Revenue USD Bn)

  • Oncology
  • Cardiology
  • Thyroid
  • Others

Nuclear Medicine Therapeutics Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Bn)

  • Hospitals
  • Imaging Centres
  • Academic & Research Centre
  • Others

Nuclear Medicine Therapeutics Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM

Middle East & Africa

  • South Africa
  • GCC
  • Rest of MEA

Table of Contents

1. Research Methodology
1.1. Study Objectives
1.2. Study Scope
1.3. Research Assumptions
1.4. Research Framework
2. Introduction
2.1. Market Definition
2.2. Global Nuclear Medicine Therapeutics Market Overview
3. Executive Summary
4. Market Environment Analysis
4.1. Porter’s 5 Forces Analysis
4.2. PESTEL Analysis
4.3. SWOT Analysis
5. Market Dynamics
5.1. Drivers Analysis
5.2. Restraints Analysis
5.3. Opportunities Analysis
5.4. Threats Analysis
5.5. Trend Analysis
6. COVID-19 Impact Analysis
7. Nuclear Medicine Therapeutics Market: Type Estimates & Trend Analysis
7.1. Type Segment Opportunity Analysis
7.2. Diagnostic Nuclear Medicine
7.2.1. Diagnostic Nuclear Medicine Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.2.2. SPECT Radiopharmaceuticals
7.2.2.1. SPECT Radiopharmaceuticals Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.2.3. PET Radiopharmaceuticals
7.2.3.1. PET Radiopharmaceuticals Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.3. Therapeutic Nuclear Medicine
7.3.1. Therapeutic Nuclear Medicine Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.3.2. Alpha Emitters
7.3.2.1. Alpha Emitters Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.3.3. Beta Emitters
7.3.3.1. Beta Emitters Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.4. Brachytherapy Isotopes
7.4.1. Brachytherapy Isotopes Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8. Nuclear Medicine Therapeutics Market: Application Estimates & Trend Analysis
8.1. Application Segment Opportunity Analysis
8.2. Oncology
8.2.1. Oncology Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.3. Cardiology
8.3.1. Cardiology Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.4. Thyroid
8.4.1. Thyroid Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.5. Others
8.5.1. Others Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9. Nuclear Medicine Therapeutics Market: End-user Estimates & Trend Analysis
9.1. End-user Segment Opportunity Analysis
9.2. Hospitals
9.2.1. Hospitals Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9.3. Imaging Centres
9.3.1. Imaging Centres Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9.4. Academic & Research Centre
9.4.1. Academic & Research Centre Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9.5. Others
9.5.1. Others Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
10. Regional Market Analysis
10.1. Regional Market Opportunity Analysis
11. North America Nuclear Medicine Therapeutics Market
11.1. North America Nuclear Medicine Therapeutics Market
11.1.1. North America Nuclear Medicine Therapeutics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.1.2. North America Nuclear Medicine Therapeutics Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
11.1.3. North America Nuclear Medicine Therapeutics Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
11.1.4. North America Nuclear Medicine Therapeutics Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
11.1.5. North America Nuclear Medicine Therapeutics Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
11.2. U.S. Global Nuclear Medicine Therapeutics Market
11.2.1. U.S. Nuclear Medicine Therapeutics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.2.2. U.S. Nuclear Medicine Therapeutics Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
11.2.3. U.S. Nuclear Medicine Therapeutics Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
11.2.4. U.S. Nuclear Medicine Therapeutics Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
11.3. Canada Global Nuclear Medicine Therapeutics Market
11.3.1. Canada Nuclear Medicine Therapeutics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.3.2. Canada Nuclear Medicine Therapeutics Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
11.3.3. Canada Nuclear Medicine Therapeutics Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
11.3.4. Canada Nuclear Medicine Therapeutics Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12. Europe Global Nuclear Medicine Therapeutics Market
12.1. Europe Global Nuclear Medicine Therapeutics Market
12.1.1. Europe Nuclear Medicine Therapeutics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.1.2. Europe Nuclear Medicine Therapeutics Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
12.1.3. Europe Nuclear Medicine Therapeutics Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
12.1.4. Europe Nuclear Medicine Therapeutics Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
12.1.5. Europe Nuclear Medicine Therapeutics Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12.2. Germany Global Nuclear Medicine Therapeutics Market
12.2.1. Germany Nuclear Medicine Therapeutics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.2.2. Germany Nuclear Medicine Therapeutics Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
12.2.3. Germany Nuclear Medicine Therapeutics Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
12.2.4. Germany Nuclear Medicine Therapeutics Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12.3. UK Global Nuclear Medicine Therapeutics Market
12.3.1. UK Nuclear Medicine Therapeutics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.3.2. UK Nuclear Medicine Therapeutics Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
12.3.3. UK Nuclear Medicine Therapeutics Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
12.3.4. UK Nuclear Medicine Therapeutics Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12.4. France Global Nuclear Medicine Therapeutics Market
12.4.1. France Nuclear Medicine Therapeutics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.4.2. France Nuclear Medicine Therapeutics Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
12.4.3. France Nuclear Medicine Therapeutics Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
12.4.4. France Nuclear Medicine Therapeutics Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12.5. Spain Global Nuclear Medicine Therapeutics Market
12.5.1. Spain Nuclear Medicine Therapeutics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.5.2. Spain Nuclear Medicine Therapeutics Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
12.5.3. Spain Nuclear Medicine Therapeutics Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
12.5.4. Spain Nuclear Medicine Therapeutics Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12.6. Italy Global Nuclear Medicine Therapeutics Market
12.6.1. Italy Nuclear Medicine Therapeutics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.6.2. Italy Nuclear Medicine Therapeutics Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
12.6.3. Italy Nuclear Medicine Therapeutics Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
12.6.4. Italy Nuclear Medicine Therapeutics Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12.7. Rest of Europe Global Nuclear Medicine Therapeutics Market
12.7.1. Rest of Europe Nuclear Medicine Therapeutics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.7.2. Rest of Europe Nuclear Medicine Therapeutics Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
12.7.3. Rest of Europe Nuclear Medicine Therapeutics Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
12.7.4. Rest of Europe Nuclear Medicine Therapeutics Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13. Asia Pacific Global Nuclear Medicine Therapeutics Market
13.1. Asia Pacific Global Nuclear Medicine Therapeutics Market
13.1.1. Asia Pacific Nuclear Medicine Therapeutics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.1.2. Asia Pacific Nuclear Medicine Therapeutics Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
13.1.3. Asia Pacific Nuclear Medicine Therapeutics Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
13.1.4. Asia Pacific Nuclear Medicine Therapeutics Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
13.1.5. Asia Pacific Nuclear Medicine Therapeutics Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13.2. Japan Global Nuclear Medicine Therapeutics Market
13.2.1. Japan Nuclear Medicine Therapeutics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.2.2. Japan Nuclear Medicine Therapeutics Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
13.2.3. Japan Nuclear Medicine Therapeutics Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
13.2.4. Japan Nuclear Medicine Therapeutics Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13.3. China Global Nuclear Medicine Therapeutics Market
13.3.1. China Nuclear Medicine Therapeutics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.3.2. China Nuclear Medicine Therapeutics Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
13.3.3. China Nuclear Medicine Therapeutics Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
13.3.4. China Nuclear Medicine Therapeutics Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13.4. India Global Nuclear Medicine Therapeutics Market
13.4.1. India Nuclear Medicine Therapeutics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.4.2. India Nuclear Medicine Therapeutics Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
13.4.3. India Nuclear Medicine Therapeutics Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
13.4.4. India Nuclear Medicine Therapeutics Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13.5. South Korea Global Nuclear Medicine Therapeutics Market
13.5.1. South Korea Nuclear Medicine Therapeutics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.5.2. South Korea Nuclear Medicine Therapeutics Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
13.5.3. South Korea Nuclear Medicine Therapeutics Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
13.5.4. South Korea Nuclear Medicine Therapeutics Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13.6. Australia Global Nuclear Medicine Therapeutics Market
13.6.1. Australia Nuclear Medicine Therapeutics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.6.2. Australia Nuclear Medicine Therapeutics Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
13.6.3. Australia Nuclear Medicine Therapeutics Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
13.6.4. Australia Nuclear Medicine Therapeutics Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13.7. Rest of Asia Pacific Global Nuclear Medicine Therapeutics Market
13.7.1. Rest of Asia Pacific Nuclear Medicine Therapeutics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.7.2. Rest of Asia Pacific Nuclear Medicine Therapeutics Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
13.7.3. Rest of Asia Pacific Nuclear Medicine Therapeutics Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
13.7.4. Rest of Asia Pacific Nuclear Medicine Therapeutics Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
14. Latin America Global Nuclear Medicine Therapeutics Market
14.1. Latin America Global Nuclear Medicine Therapeutics Market
14.1.1. Latin America Nuclear Medicine Therapeutics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.1.2. Latin America Nuclear Medicine Therapeutics Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
14.1.3. Latin America Nuclear Medicine Therapeutics Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
14.1.4. Latin America Nuclear Medicine Therapeutics Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
14.1.5. Latin America Nuclear Medicine Therapeutics Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
14.2. Brazil Global Nuclear Medicine Therapeutics Market
14.2.1. Brazil Nuclear Medicine Therapeutics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.2.2. Brazil Nuclear Medicine Therapeutics Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
14.2.3. Brazil Nuclear Medicine Therapeutics Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
14.2.4. Brazil Nuclear Medicine Therapeutics Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
14.3. Mexico Global Nuclear Medicine Therapeutics Market
14.3.1. Mexico Nuclear Medicine Therapeutics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.3.2. Mexico Nuclear Medicine Therapeutics Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
14.3.3. Mexico Nuclear Medicine Therapeutics Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
14.3.4. Mexico Nuclear Medicine Therapeutics Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
14.4. Argentina Global Nuclear Medicine Therapeutics Market
14.4.1. Argentina Nuclear Medicine Therapeutics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.4.2. Argentina Nuclear Medicine Therapeutics Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
14.4.3. Argentina Nuclear Medicine Therapeutics Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
14.4.4. Argentina Nuclear Medicine Therapeutics Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
14.5. Rest of Latin America Global Nuclear Medicine Therapeutics Market
14.5.1. Rest of Latin America Nuclear Medicine Therapeutics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.5.2. Rest of Latin America Nuclear Medicine Therapeutics Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
14.5.3. Rest of Latin America Nuclear Medicine Therapeutics Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
14.5.4. Rest of Latin America Nuclear Medicine Therapeutics Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
15. MEA Global Nuclear Medicine Therapeutics Market
15.1. MEA Global Nuclear Medicine Therapeutics Market
15.1.1. MEA Nuclear Medicine Therapeutics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.1.2. MEA Nuclear Medicine Therapeutics Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
15.1.3. MEA Nuclear Medicine Therapeutics Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
15.1.4. MEA Nuclear Medicine Therapeutics Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
15.1.5. MEA Nuclear Medicine Therapeutics Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
15.2. GCC Global Nuclear Medicine Therapeutics Market
15.2.1. GCC Nuclear Medicine Therapeutics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.2.2. GCC Nuclear Medicine Therapeutics Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
15.2.3. GCC Nuclear Medicine Therapeutics Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
15.2.4. GCC Nuclear Medicine Therapeutics Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
15.3. South Africa Global Nuclear Medicine Therapeutics Market
15.3.1. South Africa Nuclear Medicine Therapeutics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.3.2. South Africa Nuclear Medicine Therapeutics Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
15.3.3. South Africa Nuclear Medicine Therapeutics Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
15.3.4. South Africa Nuclear Medicine Therapeutics Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
15.4. Rest of MEA Global Nuclear Medicine Therapeutics Market
15.4.1. Rest of MEA Nuclear Medicine Therapeutics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.4.2. Rest of MEA Nuclear Medicine Therapeutics Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
15.4.3. Rest of MEA Nuclear Medicine Therapeutics Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
15.4.4. Rest of MEA Nuclear Medicine Therapeutics Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
16. Competitor Analysis
16.1. Company Market Share Analysis, 2023
16.2. Major Recent Developments
17. Company Profiles
17.1. Lantheus Medical Imaging, Inc.
17.2. IBA Group
17.3. Advanced Accelerator Applications S.A.
17.4. Medtronic, plc.
17.5. General Electric Co.
17.6. Bayer AG
17.7. Bracco Imaging S.p.A
17.8. Cardinal Health, Inc.
17.9. NTP Radioisotopes SOC Ltd.
17.10. Mallinckrodt plc.
17.11. Other Prominent Players
18. Conclusion19. Recommendations

Companies Mentioned

  • Lantheus Medical Imaging Inc.
  • IBA Group
  • Advanced Accelerator Applications S.A.
  • Medtronic Plc.
  • General Electric Co.
  • Bayer AG
  • Bracco Imaging S.p.A
  • Cardinal Health Inc.
  • NTP Radioisotopes SOC Ltd.
  • Mallinckrodt plc.

Table Information